🇺🇸 FDA
Patent

US 7820695

Selective serotonin receptor inverse agonists as therapeutics for disease

granted A61KA61K31/137A61K31/445

Quick answer

US patent 7820695 (Selective serotonin receptor inverse agonists as therapeutics for disease) held by ACADIA Pharmaceuticals Inc. expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/137, A61K31/445, A61P, A61P25/00